Events News Investors Contact PATIENTS PRACTICE RESEARCH ABOUT WE ARE THE GLOBAL LEADERS Chemotherapy-induced hair loss is widely recognised as one of the most traumatic side effects associated with cancer treatment, and yet it is still one of the least explored. We are changing that. Paxman has been pioneering scalp cooling technology for over a quarter of a century. Our clinically proven cold cap system has helped over 100,000 cancer patients in more than 50 countries worldwide to retain their hair during chemotherapy. Read our statement on working during COVID19 100K+ PATIENTS TREATED 50+ COUNTRIES WORLDWIDE 1 PATIENT CHOICE PATIENTS Are you looking for patient information? PRACTICE Are you looking for clinical and technical information? RESEARCH The science and development behind scalp cooling. ABOUT US Find out all about Paxman the family business. NEWS INVESTORS JOIN US SIGN UP FOR UPDATES PATIENTS Events News Investors Contact PRACTICE PSCS Procedure Clinical Efficacy Media Pack RESEARCH The Science Research Partners Global Studies USA Study ABOUT Our Story Join Us Distributors Global Partners © Paxman 2020 Site by The Engine Room Privacy & CookiesReferences and Data